UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Biochimie, ISSN 0300-9084, 12/2015, Volume 119, pp. 175 - 182
Signal transduction | Proliferation | Interleukin-11 | Proteolysis | Plasticity | Interleukin-6 | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Protein Subunits | Receptors, Interleukin-6 - chemistry | Cell Proliferation | Cytokine Receptor gp130 - genetics | Humans | Interleukin-11 Receptor alpha Subunit - agonists | Cytokine Receptor gp130 - agonists | Interleukin-6 Receptor alpha Subunit - metabolism | Interleukin-6 Receptor alpha Subunit - agonists | Protein Interaction Domains and Motifs | Interleukin-11 Receptor alpha Subunit - genetics | Binding Sites | Interleukin-6 - metabolism | Peptide Fragments - genetics | Protein Structure, Tertiary | Recombinant Proteins - metabolism | Cell Line | Peptide Fragments - metabolism | Cytokine Receptor gp130 - metabolism | Interleukin-6 - genetics | Signal Transduction | Receptors, Interleukin-6 - genetics | Cytokine Receptor gp130 - chemistry | Models, Molecular | Recombinant Proteins - chemistry | Interleukin-11 - genetics | Interleukin-11 - metabolism | Interleukin-11 Receptor alpha Subunit - metabolism | Interleukin-6 Receptor alpha Subunit - chemistry | Interleukin-6 Receptor alpha Subunit - genetics | Peptide Fragments - chemistry | Animals | Interleukin-11 Receptor alpha Subunit - chemistry | Peptide Fragments - agonists | Ligands | Mice | Receptors, Interleukin-6 - agonists | Receptors, Interleukin-6 - metabolism | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 11/2007, Volume 110, Issue 9, pp. 1911 - 1928
Interleukin-6 receptor | Translational therapeutics | Monoclonal antibody | Interleukin-6 | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Neoplasms - metabolism | Animals | Humans | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Interleukin-6 - metabolism | Drug Delivery Systems | Neoplasms - drug therapy | Receptors, Interleukin-6 - metabolism | Physiological aspects | Genetic aspects | Research | Genetic translation | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 04/2018, Volume 48, Issue 4, pp. 745 - 759.e6
signaling | T cell activation | receptor I downregulation | autoimmunity | NF-kB | TCR signaling | T cell quiescence | TGF-β | CARD11 | IL-6 | Life Sciences & Biomedicine | Immunology | Science & Technology | Cell Proliferation | Humans | Transforming Growth Factor beta1 - metabolism | Colitis - pathology | NF-kappa B - metabolism | CARD Signaling Adaptor Proteins - genetics | CD4-Positive T-Lymphocytes - immunology | Receptor, Transforming Growth Factor-beta Type I - metabolism | Signal Transduction - immunology | CARD Signaling Adaptor Proteins - metabolism | Lymphocyte Activation - immunology | Autoimmunity - immunology | HEK293 Cells | Lupus Erythematosus, Systemic - immunology | Receptors, Antigen, T-Cell - immunology | Colitis - immunology | Transforming Growth Factor beta1 - biosynthesis | Disease Models, Animal | Cell Line | Receptor, Transforming Growth Factor-beta Type I - biosynthesis | Mice, Inbred C57BL | Guanylate Cyclase - metabolism | Mice, Knockout | Animals | Down-Regulation - immunology | Interleukin-6 - immunology | Guanylate Cyclase - genetics | Mice | Mice, Inbred BALB C | Cell proliferation | NF-κB protein | Antigens | Transcription factors | Statistical analysis | Research & development--R&D | Transforming growth factor | Interleukin | Caspase | Autoantigens | Lymphocytes T | T cell receptors | Experiments | Interleukin 6 | Proteins | T-cell receptor | Mitigation | Studies | Signaling | Cell activation | Lymphocytes | Index Medicus
Journal Article
Journal of autoimmunity, ISSN 0896-8411, 2011, Volume 37, Issue 3, pp. 190 - 197
Allergy and Immunology | Intravenous immunoglobulin | B lymphocyte | TLR9 | Autoimmune diseases | Life Sciences & Biomedicine | Immunology | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Biological and medical sciences | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - immunology | Humans | Toll-Like Receptor 9 - genetics | Molecular Sequence Data | Sialic Acid Binding Ig-like Lectin 2 - immunology | Toll-Like Receptor 9 - agonists | Toll-Like Receptor 9 - immunology | Signal Transduction - immunology | Lymphocyte Activation - immunology | Flow Cytometry | Sialic Acid Binding Ig-like Lectin 2 - metabolism | Toll-Like Receptor 7 - immunology | Myeloid Differentiation Factor 88 - immunology | Autoimmune Diseases - metabolism | Autoimmune Diseases - pathology | Autoimmune Diseases - drug therapy | B-Lymphocytes - metabolism | Interleukin-2 Receptor alpha Subunit - immunology | Toll-Like Receptor 7 - agonists | Toll-Like Receptor 7 - genetics | Amino Acid Sequence | B-Lymphocytes - cytology | Toll-Like Receptor 7 - metabolism | Autoimmune Diseases - immunology | Cells, Cultured | Reverse Transcriptase Polymerase Chain Reaction | Immunoglobulins, Intravenous - pharmacology | B-Lymphocytes - drug effects | B-Lymphocytes - immunology | Interleukin-2 Receptor alpha Subunit - metabolism | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - metabolism | Lymphocyte Activation - drug effects | Interleukin-6 - biosynthesis | Interleukin-10 - biosynthesis | Oligodeoxyribonucleotides - pharmacology | Toll-Like Receptor 9 - metabolism | Myeloid Differentiation Factor 88 - metabolism | Employee recruitment | Enzymes | Phosphatases | Immunoglobulin G | Index Medicus | Oligodeoxyribonucleotides | Interleukin-2 Receptor alpha Subunit | Signal Transduction | Interleukin-10 | Lymphocyte Activation | Toll-Like Receptor 9 | B-Lymphocytes | Myeloid Differentiation Factor 88 | Toll-Like Receptor 7 | Interleukin-6 | Life Sciences | Autoimmune Diseases | Sialic Acid Binding Ig-like Lectin 2 | Protein Tyrosine Phosphatase, Non-Receptor Type 6 | Immunoglobulins, Intravenous
Journal Article
The Lancet (British edition), ISSN 0140-6736, 03/2012, Volume 379, Issue 9822, pp. 1214 - 1224
Internal Medicine | C-REACTIVE PROTEIN | RHEUMATOID-ARTHRITIS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | SOLUBLE IL-6 | INDIVIDUAL PARTICIPANTS DATA | JOINT ANALYSIS | IL-6 RECEPTOR | GENOME-WIDE ASSOCIATION | TOCILIZUMAB | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Antibodies, Monoclonal, Humanized - adverse effects | Gene Frequency - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Genetic Association Studies | Receptors, Interleukin-6 - genetics | Humans | Inflammation Mediators - blood | Genotype | Treatment Outcome | Receptors, Interleukin-6 - antagonists & inhibitors | Signal Transduction - genetics | Randomized Controlled Trials as Topic | Coronary Disease - prevention & control | Phenotype | Coronary Disease - genetics | Signal Transduction - drug effects | Mendelian Randomization Analysis | Polymorphism, Single Nucleotide - genetics | Genetic Variation - genetics | Prevention | Drug therapy | Health aspects | Risk factors | Interleukin-6 | Cytokine receptors | Physiological aspects | Genetic aspects | Research | Studies | Medical research | Cardiovascular disease | Cholesterol | Cancer | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Stroke (1970), ISSN 0039-2499, 05/2018, Volume 49, Issue 5, pp. 1210 - 1216
Brain ischemia | Clinical trial | Stroke | C-reactive protein | Interleukin-1 receptor antagonist | Interleukin-6 | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Double-Blind Method | Area Under Curve | Humans | Middle Aged | Male | Treatment Outcome | Inflammation | Stroke - drug therapy | Tissue Plasminogen Activator - therapeutic use | Brain Ischemia - immunology | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Brain Ischemia - drug therapy | Fibrinolytic Agents - therapeutic use | Injections, Subcutaneous | Thrombolytic Therapy | Interleukin-6 - immunology | Aged, 80 and over | Female | Aged | Odds Ratio | C-Reactive Protein - immunology | Stroke - immunology | Stroke (Disease) | Cerebral ischemia | Care and treatment | Interleukin-1 | Prognosis | Analysis | Clinical trials | Research | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 04/2014, Volume 82, Issue 15, pp. 1302 - 1306
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Diseases of visual field, optic nerve, optic chiasma and optic tracts | Cerebrospinal fluid. Meninges. Spinal cord | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Ophthalmology | Nervous system (semeiology, syndromes) | Antibodies, Monoclonal, Humanized - adverse effects | Neuromyelitis Optica - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Fatigue - drug therapy | Humans | Middle Aged | Male | Treatment Outcome | Receptors, Interleukin-6 - antagonists & inhibitors | Secondary Prevention | Neuralgia - drug therapy | Pilot Projects | Adult | Female | Index Medicus | Abridged Index Medicus | 132 | 224
Journal Article
Annual review of pharmacology and toxicology, ISSN 0362-1642, 2012, Volume 52, Issue 1, pp. 199 - 219
Autoimmune | Inflammation | Tocilizumab | Humanized anti-interleukin-6 receptor antibody | Interleukin-6 | Biological and medical sciences | Medical sciences | Blood. Blood coagulation. Reticuloendothelial system | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Th1 Cells - drug effects | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Autoimmune Diseases - immunology | Inflammation - immunology | Receptors, Interleukin-6 - antagonists & inhibitors | Randomized Controlled Trials as Topic | T-Lymphocytes, Regulatory - drug effects | Th17 Cells - drug effects | Animals | Cell Differentiation - drug effects | Inflammation - drug therapy | Interleukin-6 - immunology | Receptors, Interleukin-6 - immunology | Drug Delivery Systems - methods | Autoimmune Diseases - drug therapy | Disease Models, Animal | Physiological aspects | Research | Interleukins | Pharmacokinetics | Health aspects | Index Medicus
Journal Article